Todd Wider - Net Worth and Insider Trading

Todd Wider Net Worth

The estimated net worth of Todd Wider is at least $2 Million dollars as of 2024-06-10. Todd Wider is the Director of ASP Isotopes Inc and owns about 494,844 shares of ASP Isotopes Inc (ASPI) stock worth over $2 Million. Todd Wider is also the Director of Abeona Therapeutics Inc and owns about 0 shares of Abeona Therapeutics Inc (ABEO) stock worth over $0. Details can be seen in Todd Wider's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Todd Wider has not made any transactions after 2023-10-26 and currently still holds the listed stock(s).

Transaction Summary of Todd Wider

Todd Wider Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Todd Wider owns 9 companies in total, including Abeona Therapeutics Inc (ABEO) , ARYA Sciences Acquisition Corp III (ARYA) , and ARYA Sciences Acquisition Corp (ARYAU) among others .

Click here to see the complete history of Todd Wider’s form 4 insider trades.

Insider Ownership Summary of Todd Wider

Ticker	Comapny	Transaction Date	Type of Owner
ABEO	Abeona Therapeutics Inc	2021-10-07	director
ARYA	ARYA Sciences Acquisition Corp III	2020-08-06	director
ARYAU	ARYA Sciences Acquisition Corp	2020-07-01	director
		2020-06-04	director
		2020-06-04	director
		2020-08-06	director
		2021-02-25	director
		2021-07-12	director
		2023-10-26	director

Todd Wider Latest Holdings Summary

Todd Wider currently owns a total of 2 stocks. Among these stocks, Todd Wider owns 494,844 shares of ASP Isotopes Inc (ASPI) as of October 26, 2023, with a value of $2 Million and a weighting of 100%. Todd Wider also owns 0 shares of Abeona Therapeutics Inc (ABEO) as of October 7, 2021, with a value of $0 and a weighting of 0%.

Latest Holdings of Todd Wider

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
ASPI	ASP Isotopes Inc	2023-10-26	494,844	3.86	1,910,147
ABEO	Abeona Therapeutics Inc	2021-10-07	0	4.28	0

Holding Weightings of Todd Wider

Todd Wider Form 4 Trading Tracker

According to the SEC Form 4 filings, Todd Wider has made a total of 1 transactions in ASP Isotopes Inc (ASPI) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in ASP Isotopes Inc is the acquisition of 94,844 shares on October 26, 2023, which cost Todd Wider around $91,050.

According to the SEC Form 4 filings, Todd Wider has made a total of 7 transactions in Abeona Therapeutics Inc (ABEO) over the past 5 years, including 0 buys and 7 sells. The most-recent trade in Abeona Therapeutics Inc is the sale of 1,000 shares on October 7, 2021, which brought Todd Wider around $24,250.

Insider Trading History of Todd Wider

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Todd Wider Trading Performance

GuruFocus tracks the stock performance after each of Todd Wider's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Todd Wider is 27.66%. GuruFocus also compares Todd Wider's trading performance to market benchmark return within the same time period. The performance of stocks bought by Todd Wider within 3 months outperforms 1 times out of 3 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Todd Wider's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Todd Wider

Average Return

Average return per transaction

Outperforming Transactions

1 out of 2 outperforming transactions.

Each transaction is measured over a period and compared to .

	1 Month	3 Months	6 Months	1 Year	2 Years	3 Years
Return(%)	33.67
Relative Return to S&P 500(%)	32.34

Todd Wider Ownership Network

Ownership Network List of Todd Wider

No Data

Ownership Network Relation of Todd Wider

Todd Wider Owned Company Details

What does Abeona Therapeutics Inc do?

Who are the key executives at Abeona Therapeutics Inc?

Todd Wider is the director of Abeona Therapeutics Inc. Other key executives at Abeona Therapeutics Inc include SVP & General Counsel Brendan M. O'malley , director & Chief Executive Officer Vishwas Seshadri , and Chief Financial Officer Joseph Walter Vazzano .

Abeona Therapeutics Inc (ABEO) Insider Trades Summary

Over the past 18 months, Todd Wider made no insider transaction in Abeona Therapeutics Inc (ABEO). Other recent insider transactions involving Abeona Therapeutics Inc (ABEO) include a net sale of 7,443 shares made by Michael Amoroso , a net purchase of 50,000 shares made by Vishwas Seshadri , and a net sale of 14,287 shares made by Mark Alvino .

In summary, during the past 3 months, insiders sold 0 shares of Abeona Therapeutics Inc (ABEO) in total and bought 42,758 shares, with a net purchase of 42,758 shares. During the past 18 months, 43,636 shares of Abeona Therapeutics Inc (ABEO) were sold and 88,758 shares were bought by its insiders, resulting in a net purchase of 45,122 shares.

Abeona Therapeutics Inc (ABEO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Abeona Therapeutics Inc Insider Transactions

No Available Data

What does ARYA Sciences Acquisition Corp III do?

Who are the key executives at ARYA Sciences Acquisition Corp III?

Todd Wider is the director of ARYA Sciences Acquisition Corp III. Other key executives at ARYA Sciences Acquisition Corp III include director & 10 percent owner & Chief Executive Officer Adam Leo Stone , director & 10 percent owner & Chief Financial Officer Michael Seth Altman , and 10 percent owner Arya Sciences Holdings Iii .

ARYA Sciences Acquisition Corp III (ARYA) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of ARYA Sciences Acquisition Corp III (ARYA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of ARYA Sciences Acquisition Corp III (ARYA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

ARYA Sciences Acquisition Corp III (ARYA)'s detailed insider trading history can be found in Insider Trading Tracker table.

ARYA Sciences Acquisition Corp III Insider Transactions

No Available Data

What does ARYA Sciences Acquisition Corp do?

Who are the key executives at ARYA Sciences Acquisition Corp?

Todd Wider is the director of ARYA Sciences Acquisition Corp. Other key executives at ARYA Sciences Acquisition Corp include director & Chief Executive Officer Adam Leo Stone , and director & Chief Financial Officer Michael Seth Altman .

ARYA Sciences Acquisition Corp (ARYAU) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of ARYA Sciences Acquisition Corp (ARYAU) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of ARYA Sciences Acquisition Corp (ARYAU) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

ARYA Sciences Acquisition Corp (ARYAU)'s detailed insider trading history can be found in Insider Trading Tracker table.

ARYA Sciences Acquisition Corp Insider Transactions

No Available Data

What does ARYA Sciences Acquisition Corp II do?

Who are the key executives at ARYA Sciences Acquisition Corp II?

Todd Wider is the director of ARYA Sciences Acquisition Corp II. Other key executives at ARYA Sciences Acquisition Corp II include director & Chief Executive Officer Adam Leo Stone , director & Chief Financial Officer Michael Seth Altman , and 10 percent owner Arya Sciences Holdings Ii .

ARYA Sciences Acquisition Corp II (ARYBU) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of ARYA Sciences Acquisition Corp II (ARYBU) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of ARYA Sciences Acquisition Corp II (ARYBU) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

ARYA Sciences Acquisition Corp II (ARYBU)'s detailed insider trading history can be found in Insider Trading Tracker table.

ARYA Sciences Acquisition Corp II Insider Transactions

No Available Data

What does Cerevel Therapeutics Holdings Inc do?

Who are the key executives at Cerevel Therapeutics Holdings Inc?

Todd Wider is the director of Cerevel Therapeutics Holdings Inc. Other key executives at Cerevel Therapeutics Holdings Inc include director & See Remarks N Anthony Coles , Chief Scientific Officer John Renger , and Chief Medical Officer Ramiro Sanchez .

Cerevel Therapeutics Holdings Inc (CERE) Insider Trades Summary

Over the past 18 months, Todd Wider made no insider transaction in Cerevel Therapeutics Holdings Inc (CERE). Other recent insider transactions involving Cerevel Therapeutics Holdings Inc (CERE) include a net sale of 852,506 shares made by N Anthony Coles , a net sale of 37,652 shares made by Ramiro Sanchez , and a net sale of 24,572 shares made by Scott Akamine .

In summary, during the past 3 months, insiders sold 150,000 shares of Cerevel Therapeutics Holdings Inc (CERE) in total and bought 0 shares, with a net sale of 150,000 shares. During the past 18 months, 1,191,157 shares of Cerevel Therapeutics Holdings Inc (CERE) were sold and 17,422,701 shares were bought by its insiders, resulting in a net purchase of 16,231,544 shares.

Cerevel Therapeutics Holdings Inc (CERE)'s detailed insider trading history can be found in Insider Trading Tracker table.

Cerevel Therapeutics Holdings Inc Insider Transactions

No Available Data

What does Nautilus Biotechnology Inc do?

Who are the key executives at Nautilus Biotechnology Inc?

Todd Wider is the director of Nautilus Biotechnology Inc. Other key executives at Nautilus Biotechnology Inc include director & 10 percent owner & CEO & President & and Secretary Sujal M Patel , Senior VP & Product Development Subramanian Sankar , and Chief People Officer Gwen E Weld .

Nautilus Biotechnology Inc (NAUT) Insider Trades Summary

Over the past 18 months, Todd Wider made no insider transaction in Nautilus Biotechnology Inc (NAUT). Other recent insider transactions involving Nautilus Biotechnology Inc (NAUT) include a net purchase of 50,000 shares made by Sujal M Patel ,

In summary, during the past 3 months, insiders sold 0 shares of Nautilus Biotechnology Inc (NAUT) in total and bought 14,474 shares, with a net purchase of 14,474 shares. During the past 18 months, 0 shares of Nautilus Biotechnology Inc (NAUT) were sold and 50,000 shares were bought by its insiders, resulting in a net purchase of 50,000 shares.

Nautilus Biotechnology Inc (NAUT)'s detailed insider trading history can be found in Insider Trading Tracker table.

Nautilus Biotechnology Inc Insider Transactions

No Available Data

What does ARYA Sciences Acquisition Corp IV do?

Who are the key executives at ARYA Sciences Acquisition Corp IV?

Todd Wider is the director of ARYA Sciences Acquisition Corp IV. Other key executives at ARYA Sciences Acquisition Corp IV include Chief Business Officer Konstantin Poukalov , director & 10 percent owner & Chief Executive Officer Adam Leo Stone , and director & 10 percent owner & Chief Financial Officer Michael Seth Altman .

ARYA Sciences Acquisition Corp IV (ARYD) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of ARYA Sciences Acquisition Corp IV (ARYD) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of ARYA Sciences Acquisition Corp IV (ARYD) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

ARYA Sciences Acquisition Corp IV (ARYD)'s detailed insider trading history can be found in Insider Trading Tracker table.

ARYA Sciences Acquisition Corp IV Insider Transactions

No Available Data

What does ARYA Sciences Acquisition Corp V do?

Who are the key executives at ARYA Sciences Acquisition Corp V?

Todd Wider is the director of ARYA Sciences Acquisition Corp V. Other key executives at ARYA Sciences Acquisition Corp V include Chief Business Officer Konstantin Poukalov , director & 10 percent owner & Chief Executive Officer Adam Leo Stone , and director & 10 percent owner & Chief Financial Officer Michael Seth Altman .

ARYA Sciences Acquisition Corp V (ARYE) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of ARYA Sciences Acquisition Corp V (ARYE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of ARYA Sciences Acquisition Corp V (ARYE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

ARYA Sciences Acquisition Corp V (ARYE)'s detailed insider trading history can be found in Insider Trading Tracker table.

ARYA Sciences Acquisition Corp V Insider Transactions

No Available Data

What does ASP Isotopes Inc do?

Who are the key executives at ASP Isotopes Inc?

Todd Wider is the director of ASP Isotopes Inc. Other key executives at ASP Isotopes Inc include 10 percent owner Ak Jensen Investment Management Ltd , director & 10 percent owner & Chief Executive Officer Paul Elliot Mann , and 10 percent owner & other: Chief Scientific Adviser Einar Ronander .

ASP Isotopes Inc (ASPI) Insider Trades Summary

Over the past 18 months, Todd Wider made 1 insider transaction in ASP Isotopes Inc (ASPI) with a net purchase of 94,844. Other recent insider transactions involving ASP Isotopes Inc (ASPI) include a net purchase of 53,393 shares made by , a net purchase of 224,167 shares made by Duncan Moore , and a net purchase of 104,167 shares made by Joshua Jay Donfeld .

In summary, during the past 3 months, insiders sold 0 shares of ASP Isotopes Inc (ASPI) in total and bought 35,047 shares, with a net purchase of 35,047 shares. During the past 18 months, 0 shares of ASP Isotopes Inc (ASPI) were sold and 476,571 shares were bought by its insiders, resulting in a net purchase of 476,571 shares.

ASP Isotopes Inc (ASPI)'s detailed insider trading history can be found in Insider Trading Tracker table.

ASP Isotopes Inc Insider Transactions

No Available Data

Todd Wider Mailing Address

Above is the net worth, insider trading, and ownership report for Todd Wider. You might contact Todd Wider via mailing address: 4848 Lemmon Avenue, Suite 517, Dallas Tx 75219.

Discussions on Todd Wider

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.